参考文献

1.Travis WD，Brambilla E，Nicholson AG，et al.The 2015 World Health Organization classification of lung tumors： impact of genetic， clinical and radiologic advances since the 2004 classification.J Thorac Oncol， 2015， 10（9）： 1243-1260.

2.Travis WD， Brambilla E， Burke A， et al.WHO classification of tumours of the lung， pleura，thymus and heart.2015：International Agency for Research on Cancer.

3.Rekhtman N， Ang DC， Sima CS， et al.Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.Mod Pathol， 2011， 24（10）： 1348-1359.

4.Nonaka D.A study of DeltaNp63 expression in lung non-small cell carcinomas.Am J Surg Pathol， 2012， 36（6）： 895-899.

5.Cunha SG，Saieg MA.Cell blocks for subtyping and molecular studies in non-small cell lung carcinoma.Cytopathology， 2015， 26（5）： 331-333.

6.Kapila K，Al-Ayadhy B，Francis IM，et al.Subclassification of pulmonary non-small cell lung carcinoma in fine needle aspirates using a limited immunohistochemistry panel.J Cytol， 2013，30（4）： 223-225.

7.Kimbrell HZ，Gustafson KS，Huang M，et al.Subclassification of non-small cell lung cancer by cytologic sampling：a logical approach with selective use of immunocytochemistry.Acta Cytol， 2012， 56（4）： 419-424.

8.Treece AL，Montgomery ND，Patel NM，et al.FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.Cancer Cytopathol， 2016， 124（6）： 406-414.

9.Betz BL， Dixon CA， Weigelin HC， et al.The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.Cancer Cytopathol， 2013， 121（9）：489-499.

10.Hasleton P， Flieder DB.Spencer′s Pathology of the Lung.6th ed.Cambridge University Press，2013.

11.Butnor KJ， Beasley MB， Cagle PT， et al.Protocol for the examination of specimens from patients with primary non-small cell carcinoma， small cell carcinoma， or carcinoid tumor of the lung.Arch Pathol Lab Med， 2009， 133（10）： 1552-1559.

12.Travis WD， Brambilla E， Rami-Porta R， et al.Visceral pleural invasion： pathologic criteria and use of elastic stains：proposal for the 7th edition of the TNM classification for lung cancer.J Thorac Oncol， 2008， 3（12）： 1384-1390.

13.Leighl NB， Rekhtman N， Biermann WA， et al.Molecular testing for selection of patients with lung cancer for epidermal growth factor receptor and anaplastic lymphoma kinase tyrosine kinase inhibitors：American Society of Clinical Oncology endorsement of the College of American Pathologists/International Association for the study of lung cancer/association for molecular pathologyguideline.J Clin Oncol， 2014， 32（32）： 3673-3679.